RZNOMICS Advances High-Efficiency Circular RNA Production
Seoul, South Korea, September 7, 2026 RZNOMICS Inc., a biopharmaceutical company focused on RNA-based gene therapies, has reported major...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Seoul, South Korea, September 7, 2026 RZNOMICS Inc., a biopharmaceutical company focused on RNA-based gene therapies, has reported major...
BOSTON, Massachusetts, USA, June 3, 2026 Ascidian Therapeutics and Eli Lilly and Company have entered into a landmark global...
SAN CARLOS, Calif., May 22, 2026 Eli Lilly and Company has acquired Engage Bio, a preclinical biotechnology company focused...
VANCOUVER, Canada — December 4, 2025 — Renaissance BioScience Corp. announced that the Mexican patent office has granted a...
